Please login to the form below

Not currently logged in
Email:
Password:

EU vows to cut fake pharmaceuticals

New legislation from the EU aims to address the increase in the number of dangerous counterfeit drugs making their way across Europe

New legislation from the EU aims to address the increase in the number of dangerous counterfeit drugs making their way across Europe.

Under the new rules, all pharmaceuticals in the EU will be traceable from the point of manufacture to the pharmacy. This will also include active ingredients that are sourced from outside the EU, ensuring they are produced to the same standards as EU-sourced ingredients.

Previously, the 27 member countries were used to transit counterfeit medicines to third world countries. Now, they are the targets for these substances. Switzerland produces more counterfeit drugs than anywhere else in the world. The use of the internet has lead to an increase in ordering of fake therapies, most notably Viagra, by EU residents.

Consumers are also set to benefit from new regulations to improve how changes to medicines are registered, ensuring they benefit more quickly and receive better information about the latest versions of drugs.

The legislation will also ensure that consistent procedures apply to medicines placed on the market across the EU, covering processes such as the updating of patient leaflets. 

22nd October 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics